![Seng Chin Mah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Seng Chin Mah is currently the Chairman at BioVersys AG.
Prior to this, he held the position of Chief Executive Officer at Canyon Pharmaceuticals, Inc.
Cargos activos de Seng Chin Mah
Empresas | Cargo | Inicio |
---|---|---|
BioVersys AG
![]() BioVersys AG Miscellaneous Commercial ServicesCommercial Services BioVersys AG operates as a holding company, which specializes in the research and development of small molecules acting on novel bacterial targets. Its research focuses on nosocomial infection and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland. | Presidente | - |
Antiguos cargos conocidos de Seng Chin Mah.
Empresas | Cargo | Fin |
---|---|---|
Canyon Pharmaceuticals, Inc.
![]() Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Canyon Pharmaceuticals, Inc.
![]() Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Health Technology |
BioVersys AG
![]() BioVersys AG Miscellaneous Commercial ServicesCommercial Services BioVersys AG operates as a holding company, which specializes in the research and development of small molecules acting on novel bacterial targets. Its research focuses on nosocomial infection and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Bolsa de valores
- Insiders
- Seng Chin Mah